1. Home
  2. LSTA vs TRT Comparison

LSTA vs TRT Comparison

Compare LSTA & TRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • TRT
  • Stock Information
  • Founded
  • LSTA 1980
  • TRT 1958
  • Country
  • LSTA United States
  • TRT United States
  • Employees
  • LSTA N/A
  • TRT N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • TRT Industrial Machinery/Components
  • Sector
  • LSTA Health Care
  • TRT Technology
  • Exchange
  • LSTA Nasdaq
  • TRT Nasdaq
  • Market Cap
  • LSTA 24.2M
  • TRT 27.6M
  • IPO Year
  • LSTA N/A
  • TRT N/A
  • Fundamental
  • Price
  • LSTA $2.58
  • TRT $6.20
  • Analyst Decision
  • LSTA Strong Buy
  • TRT
  • Analyst Count
  • LSTA 1
  • TRT 0
  • Target Price
  • LSTA $15.00
  • TRT N/A
  • AVG Volume (30 Days)
  • LSTA 19.6K
  • TRT 8.1K
  • Earning Date
  • LSTA 11-12-2024
  • TRT 02-10-2025
  • Dividend Yield
  • LSTA N/A
  • TRT N/A
  • EPS Growth
  • LSTA N/A
  • TRT N/A
  • EPS
  • LSTA N/A
  • TRT 0.24
  • Revenue
  • LSTA N/A
  • TRT $42,312,000.00
  • Revenue This Year
  • LSTA N/A
  • TRT N/A
  • Revenue Next Year
  • LSTA N/A
  • TRT N/A
  • P/E Ratio
  • LSTA N/A
  • TRT $27.14
  • Revenue Growth
  • LSTA N/A
  • TRT N/A
  • 52 Week Low
  • LSTA $2.19
  • TRT $4.64
  • 52 Week High
  • LSTA $3.83
  • TRT $7.88
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 41.13
  • TRT 38.09
  • Support Level
  • LSTA $2.48
  • TRT $6.53
  • Resistance Level
  • LSTA $2.77
  • TRT $6.88
  • Average True Range (ATR)
  • LSTA 0.19
  • TRT 0.20
  • MACD
  • LSTA -0.01
  • TRT -0.07
  • Stochastic Oscillator
  • LSTA 56.52
  • TRT 5.43

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About TRT Trio-Tech International

Trio-Tech International is a provider of third-party semiconductor testing and burn-in services through its laboratories in Southeast Asia. The company operates in four segments namely Manufacturing, Testing services, Distribution, and Real Estate. Its Manufacturing segment manufactures both front-end and back-end semiconductor test equipment and related peripherals. The Testing Services segment renders services to the manufacturer and purchaser of semiconductors and other entities. Its Distribution segment is involved in the distribution of its products. The company's Real Estate segment consists of investment in real estate. Its geographical area of operations includes the United States, Singapore, Malaysia, Thailand, and China. It derives maximum revenue from Testing services Segment.

Share on Social Networks: